Erythema Multiforme and Stevens-Johnson Syndrome

The sudden appearance of widespread, painful oral erosions with crusted lips can be alarming, and it may represent either erythema multiforme or a drug-induced severe reaction such as Stevens-Johnson syndrome. Both belong to a spectrum of immune-mediated mucocutaneous disorders, and both can begi...

The sudden appearance of widespread, painful oral erosions with crusted lips can be alarming, and it may represent either erythema multiforme or a drug-induced severe reaction such as Stevens-Johnson syndrome. Both belong to a spectrum of immune-mediated mucocutaneous disorders, and both can begin in the mouth before the skin is involved. Distinguishing them is a clinical priority, because erythema multiforme is usually self-limiting and benign, while Stevens-Johnson syndrome can be fatal and demands immediate withdrawal of the trigger.

The Spectrum of Disease

Erythema multiforme is an acute, self-limited, immune-mediated condition that most often follows an infection, herpes simplex virus being the trigger in the majority of recurrent cases. It produces target-like skin lesions, and the oral mucosa is involved in many patients, sometimes as the only manifestation. The disease typically resolves within weeks, although it recurs, especially when triggered by recurrent herpetic infection.

Stevens-Johnson syndrome and its severe variant, toxic epidermal necrolysis, are life-threatening hypersensitivity reactions, almost always drug-triggered, that cause widespread epidermal detachment and mucosal erosion. The division between them is based on the percentage of the body surface involved, below ten percent for Stevens-Johnson syndrome and above thirty percent for toxic epidermal necrolysis. Oral involvement occurs in nearly all patients and is often the first sign recognized by the dental team.

Although the two conditions share clinical features, their triggers, severity and natural history differ markedly. Erythema multiforme is typically infection-associated, mild and recurrent, whereas Stevens-Johnson syndrome is drug-associated, severe and a single acute event, with toxic epidermal necrolysis at the extreme end of the same reaction. The distinction matters because management and prognosis differ completely.

Oral Manifestations

In the mouth, erythema multiforme produces widespread, shallow, painful erosions of the lips, buccal mucosa, tongue and palate. The classic presentation is extensive hemorrhagic crusting of the lips, often mistaken for impetigo or trauma. Blisters form and rupture rapidly, leaving raw, bleeding surfaces that interfere with eating, speaking and swallowing.

Stevens-Johnson syndrome and toxic epidermal necrolysis cause severe stomatitis with extensive necrosis, marked edema and profuse crusting, and the lesions are often hemorrhagic and secondarily infected. The entire oral mucosa can desquamate, the lips become swollen and crusted, and the eyes, genitalia and gastrointestinal tract may be involved concurrently. Because oral signs can precede the skin eruption by days, a febrile patient with sudden oral ulceration and crusted lips should prompt urgent assessment.

The oral mucosa is affected in the majority of these patients and may be the presenting site, making the dentist an important early observer. Widespread erosions with lip crusting in a previously healthy patient should not be treated empirically as infection or trauma, but should prompt early recognition, referral and trigger identification.

Causes and Diagnosis

Herpes simplex virus is the most common trigger of erythema multiforme, with other infectious triggers including mycoplasma pneumoniae, the Epstein-Barr virus, cytomegalovirus and some bacterial infections. The most common triggers of Stevens-Johnson syndrome and toxic epidermal necrolysis are anticonvulsants, especially carbamazepine, phenytoin and lamotrigine, and the sulfonamide and penicillin antibiotics. Allopurinol, non-steroidal anti-inflammatory drugs and some antimalarials are also well-documented causes, and the reaction typically begins one to three weeks after starting the drug.

The diagnosis is clinical and requires a careful history of recent infection, medication use and the lesion pattern. Skin biopsy with immunofluorescence can support the diagnosis, and laboratory tests may include blood counts and inflammatory markers. Identifying and withdrawing the culprit drug is essential in the severe reactions.

Management

Erythema multiforme is managed supportively, with pain control, oral hygiene and rehydration, and usually resolves within two to three weeks. When herpes is the trigger, prophylactic antivirals such as acyclovir can reduce recurrences, and mild topical corticosteroids may shorten the acute episode. Most patients recover fully without sequelae.

Stevens-Johnson syndrome and toxic epidermal necrolysis are medical emergencies requiring admission to a burn or intensive care unit, immediate withdrawal of the offending drug, and coordinated care by dermatologists, ophthalmologists and intensivists. Treatment includes fluid and electrolyte replacement, nutritional support, pain control, prevention of infection and meticulous skin and mucosal care. Early recognition and supportive therapy are the cornerstones of management.

The dentist contributes to early recognition and the care of the oral mucosa during recovery. Bland rinses, soft diets and topical anesthetics relieve discomfort, while gentle oral hygiene prevents secondary candidal or bacterial infection. After healing, patients who have lost gingival tissue may require restorative follow-up, and those with drug-induced reactions must avoid the culprit drug permanently.

Prevention and Prognosis

The most effective prevention is avoiding the known trigger: patients with herpetic erythema multiforme should control outbreaks and consider suppressive antiviral therapy, while those with a drug-induced reaction must avoid the offending drug and related compounds forever. The diagnosis should be documented clearly with the culprit drug listed in the medical record to prevent inadvertent re-exposure.

Erythema multiforme is generally benign and self-limiting, whereas Stevens-Johnson syndrome carries a mortality of five to fifteen percent and toxic epidermal necrolysis a much higher risk. Survivors often struggle with chronic ocular dryness, esophageal strictures and genital adhesions, and may need multidisciplinary rehabilitation. Prompt recognition and early supportive care significantly improve the outcome.

During the acute phase, plaque control must be maintained gently because the oral mucosa is fragile and secondary infection delays healing. A pressure-sensing electric toothbrush such as the BrushO automatically reduces power when brushing force is excessive, allowing patients with painful oral lesions to clean the teeth without aggravating raw surfaces. Its soft bristles and two-minute timer support the consistent hygiene that reduces infection risk and helps the mucosa recover quickly.

Conclusion

Erythema multiforme and Stevens-Johnson syndrome form a spectrum of immune-mediated mucocutaneous disease in which the mouth is frequently the first site of involvement. Erythema multiforme is usually triggered by herpes and resolves with supportive care, whereas Stevens-Johnson syndrome requires urgent withdrawal of the culprit drug and specialist management. Early recognition by the dental team, careful avoidance of triggers and gentle supportive oral care together improve comfort and outcome.

（本文由 BrushO 智能牙刷团队撰写，仅供科普参考，不构成医疗建议。）（内容由AI生成，仅供参考）